Mylimus 0.1% Ointment
Manufacturer
Mylan Pharmaceuticals Pvt Ltd - A Viatris Company
Salt Composition
Tacrolimus (0.1% w/w)
Key Information
Short Description
Mylimus 0.1% Ointment is used to treat eczema (atopic dermatitis) by suppressing the activity of certain immune cells that cause inflammation (redness and swelling) of the skin.
Dosage Form
Ointment
Introduction
Mylimus 0.1% Ointment is used for external use. It should be used 2-4 times a day on the affected area or use it as suggested by the doctor. It should be applied slowly and evenly to the skin until it is rubbed in. You should not use it too often and you should not cover the treated area with a bandage or plaster. You must inform your doctor if there’s no improvement even after two weeks of treatment or if the skin gets worse. Use of this medicine may cause some common side effects like erythema, headache, inflammation of hair follicle, and application site reaction like burning, irritation, itching, and redness. This medicine is not normally recommended during pregnancy or while breastfeeding unless it is clearly needed.
Directions for Use
This medicine is for external use only. Use it in the dose and duration as advised by your doctor. Check the label for directions before use. Clean and dry the affected area and gently massage the ointment.
Safety Information
Side Effects
Erythema Headache Inflammation of hair follicle Application site reaction like burning, irritation, itching, and redness
Breastfeeding Warning
Mylimus 0.1% Ointment is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Pregnancy Warning
Mylimus 0.1% Ointment may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Interacting Medicines
Rotavirus vaccine (live attenuated, oral) Live Attenuated Varicella-Zoster Virus Measles Vaccine (Live) Rubella vaccine (Live)
How it works
Mylimus 0.1% Ointment is an immunosuppressant. It works by suppressing the activity of certain immune cells that cause inflammation (redness and swelling) of the skin. This relieves itching and improves rashes in atopic dermatitis.
Quick Tips
Apply thinly to affected areas of skin only Clean the affected area and dry well before applying Mylimus 0.1% Ointment Avoid contact with water after application Inform your doctor if there's no improvement even after two weeks of treatment or if the skin gets worse Don't cover the area being treated with airtight dressings such as bandages unless directed by a doctor Stop using Mylimus 0.1% Ointment and consult your doctor if your eczema becomes infected Continuous long-term use of the ointment should be avoided. Use as prescribed by your doctor.
Related Medicines
Talimus Ointment
Tacroz Forte 0.1% Ointment
Tacronol 0.1% Ointment
Tacroz Forte Ointment
Tacvido Forte Ointment
Tbis 0.1% Ointment
Tecum 0.1% Ointment
Tackon Forte 0.1% Ointment
Tacrox 0.1% Ointment
Atomus Ointment
Frequently asked questions
What is Mylimus 0.1% Ointment used for?
Mylimus 0.1% Ointment is a medicine that modulates the immune system to decrease its activity. It is used to treat moderate to severe eczema (atopic dermatitis) in adults who do not respond to steroids or develop side effects from using them. In atopic dermatitis, the skin's immune system undergoes an overreaction and causes skin inflammation leading to itchiness, redness, and dryness. Mylimus 0.1% Ointment acts on the abnormal immune response and alters it, thereby relieving skin inflammation and itchiness.
What are the side effects of Mylimus 0.1% Ointment?
Mylimus 0.1% Ointment, when applied to the skin, may cause mild to moderate skin irritation, burning sensation, itching at the site of application. These usually subside within one week after starting treatment. Redness is also a common manifestation along with sensations of warmth, pain, altered sensation and rash at the site of application. Using it increases the patient's risk of inflamed or infected hair follicles, cold sores, acne, and generalized herpes simplex infections.
Is Mylimus 0.1% Ointment ointment safe?
Compared to other immune-suppressing medications, Mylimus 0.1% Ointment has been found to be a safe and effective short-term treatment for atopic dermatitis. Its absorption into the blood and body is minimal when applied to the skin. Therefore, side effects are less pronounced than with oral administration.
Does Mylimus 0.1% Ointment have abuse potential?
No, Mylimus 0.1% Ointment does not have an abuse potential and thus is not a controlled substance. Controlled substances have the potential for abuse and require permission by authorities and a doctor for use.
Does Mylimus 0.1% Ointment cause cancer?
Long-term use of Mylimus 0.1% Ointment has been associated with an increased risk of lymph node tumors called lymphoma. Some studies have found that individuals using Mylimus 0.1% Ointment or similar medications developed skin cancer or lymphoma. It is important to consult your doctor if you need to use Mylimus 0.1% Ointment for more than six weeks or if your eczema symptoms do not improve or worsen during treatment.
Is Mylimus 0.1% Ointment a steroid?
No, Mylimus 0.1% Ointment is not a steroid. It is a medicine that modulates the immune system activity. It is used in the treatment of eczema, commonly known as atopic dermatitis. An advantage of Mylimus 0.1% Ointment is that it does not cause skin thinning (atrophy) or other side effects related to steroids.
